Be Ready to Prescribe Alternatives to Valsartan
The valsartan recall will continue to raise questions about how to switch to a different ARB or an ACE inhibitor.
The generic products impacted are a moving target. For now, the recall also includes some combos with hydrochlorothiazide or amlodipine.
The recalled products may have been contaminated with the probable carcinogen N-nitrosodimethylamine (NDMA) for as long as 4 years...possibly because of changes in how valsartan was made.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote